These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1100717)

  • 1. Immunochemical properties of streptococcal M protein purified by isoelectric focusing.
    Cunningham M; Beachey EH
    J Immunol; 1975 Oct; 115(4):1002-6. PubMed ID: 1100717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.
    Beachey EH; Stollerman GH; Chiang EY; Chiang TM; Seyer JM; Kang AH
    J Exp Med; 1977 Jun; 145(6):1469-83. PubMed ID: 325168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules.
    Manjula BN; Fischetti VA
    J Immunol; 1980 Jan; 124(1):261-7. PubMed ID: 6985640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity in animals and man of a structurally defined polypeptide of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Bisno AL; Ofek I
    Trans Assoc Am Physicians; 1979; 92():346-54. PubMed ID: 398625
    [No Abstract]   [Full Text] [Related]  

  • 7. [T-proteins of Streptococcus pyogenes. I. Communication: Preparation of a serological type specific T1-antigen by ion exchange chromatography and its characterization (author's transl)].
    Schmidt KH; Kühnemund O; Köhler W
    Zentralbl Bakteriol A; 1980; 246(4):475-88. PubMed ID: 6999791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M protein of type 12 Strepto coccus pyogenes. Isolation by electrofocusing and some molecular weight-dependent properties.
    Havlícek J
    Pathol Microbiol (Basel); 1975; 42(3):147-58. PubMed ID: 810761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of M proteins purified by column chromatography with hydroxyapatite from acid extracts of Streptococcus pyogenes of types 1, 3, 6, 12 and 17.
    Vosti KL
    J Med Microbiol; 1978 Nov; 11(4):453-62. PubMed ID: 364064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the antibody response to type 12 M protein of group A streptococcus.
    Noble RC; Penny BB
    J Lab Clin Med; 1975 Nov; 86(5):713-21. PubMed ID: 810528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and biological properties of soluble protein preparations from Brucella abortus.
    Tabatabai LB; Deyoe BL
    Dev Biol Stand; 1984; 56():199-211. PubMed ID: 6436094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of M protein in phagocytosis. II. Opsonization of Streptococcus pyogenes in vitro.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):44-7. PubMed ID: 44622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
    Sandin C; Carlsson F; Lindahl G
    Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunobiology of M-proteins of Streptococcus pyogenes. I. Isolation and purification of M-proteins from group A streptococci (Streptococcus pyogenes) type 1].
    Kühnemund O; Köhler W
    Allerg Immunol (Leipz); 1976; 22(2):171-8. PubMed ID: 136885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and immunobiological properties of R antigen and its relation to M protein of type 3 group A Streptococcus.
    Johnson RH; Beachey EH
    Infect Immun; 1979 Sep; 25(3):1051-9. PubMed ID: 91582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M antigens of group A streptococci isolated by means of immunochromatography. Biochemical and serological properties.
    Kühnemund O; Havlicek J; Knöll H; Sjöquist J
    Immunobiology; 1981; 159(3):244-55. PubMed ID: 7021402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.